Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
Vinit Upasani, Katie Townsend, Mary Wu, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 7, pp. 950-960
Open Access | Times Cited: 15

Showing 15 citing articles:

Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management
Suzy Meijer, Yael Paran, Ana Belkin, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 8, pp. 1012-1017
Closed Access | Times Cited: 10
Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: A retrospective cohort study
Remigius Gröning, J Walde, Clas Ahlm, et al.
International Journal of Infectious Diseases (2024) Vol. 144, pp. 107046-107046
Open Access | Times Cited: 7
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Juan G. Ripoll, Sidna M. Tulledge‐Scheitel, Anthony A. Stephenson, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 5
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
Sheila M. Keating, Brett W. Higgins
Antiviral Research (2024) Vol. 227, pp. 105902-105902
Closed Access | Times Cited: 3
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy
Mark Ballow, Raúl Ortiz-de-Lejarazu, Isabella Quinti, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023)
Samya Van Coillie, J Prévot, Silvia Sánchez‐Ramón, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Intravenous immunoglobulin as a potential treatment for long COVID
Matthew W. McCarthy
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 12, pp. 1211-1217
Closed Access | Times Cited: 3
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Replacement Therapy for Immunocompromised Patients
Jonathon W. Senefeld, Michael J. Joyner
Clinical Infectious Diseases (2023) Vol. 77, Iss. 7, pp. 961-963
Closed Access | Times Cited: 2
Secondary organizing pneumonia associated with protracted COVID: A case series
P-Y. Sansen, Emmanuel Coche, Pierre Hainaut, et al.
Infectious Diseases Now (2024) Vol. 54, Iss. 3, pp. 104888-104888
Open Access
The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review
Adam Al‐Hakim, Mark Kačar, Sinisa Savic
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1717-1717
Open Access
Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era
Dong Won Baek, Ga‐Young Song, Ho Sup Lee, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 675-675
Open Access
A multinational case series describing successful treatment of persistent SARS-CoV-2 infection caused by Omicron sublineages with prolonged courses of nirmatrelvir/ritonavir.
Luke B. Snell, Aimée McGreal-Bellone, Clemency Nye, et al.
Open Forum Infectious Diseases (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top